Tuberculosis & HIV/AIDS: Treatment

See also: Tuberculosis & HIV

HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected With HIV Receiving Antiretroviral Therapy (December 20, 2011)
Short-course (3-month) therapy with weekly isoniazid-rifapentine is NOT RECOMMENDED for HIV-infected patients receiving antiretroviral therapy.
From AIDSinfo
Earlier Versus Later Start of Antiretroviral Therapy in HIV-Infected Adults With Tuberculosis (October 31, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
AstraZeneca Joins Rival to Develop New TB Treatment (March 15, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The First New Tuberculosis Drug in Decades: Promise and Challenges (Winter 2011)
To read PDF, click here.
In TAGline, from Treatment Action Group
Inflammatory Disease Drugs Could Hold TB Treatment Key (August 20, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
TB and HIV Management in High Prevalence Settings: From Coordination to Integration (July 21, 2010)
To read PDF, click here.
From Henry J. Kaiser Family Foundation
Combination ART, TB Treatment Slash Co-Infected Patient Mortality Rates, Study Finds (February 26, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Two New Classes of TB Drugs -- the First in 40 Years -- Advance Through Phase II Studies (Winter 2010)
After 40 years of scientific stagnation, it is beginning to be an exciting time in tuberculosis treatment research.
To read PDF, click here.
In TAGline, from Treatment Action Group
IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials (July 24, 2009)
A brief recap of selected mainstream media coverage of research presented at IAS 2009.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
d4T Toxicity Risk 7-Fold Higher When Started With TB Treatment (June 18, 2009)
From aidsmap.com
Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
South Africa Tries Treating TB Patients at Home (March 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Tuberculosis Treatments and Drugs (January 28, 2009)
From Mayo Clinic
FDA Issues "Black Box" Warning for Cipro, Similar Drugs (July 9, 2008)
From Project Inform
An Overview of Isoniazid (INH, Nydrazid) (April 30, 2007)
From AIDSinfo
An Overview of Rifampin (Rifadin, Rimactane) (April 23, 2007)
From AIDSinfo
International Standards for Tuberculosis Care (PDF) (2006)
Diagnosis, treatment, public health.
From World Health Organization
Tuberculosis Treatment in Resource-Limited Settings (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Mycobacterium Tuberculosis: Treatment in the United States and Other High-Income Nations (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Virtual Medicine: Web-Based Record System Proves as Potent as Drugs in Treating Tuberculosis (August 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Tuberculosis Treatment Pipeline (July 2005)
To read PDF, click here.
From Treatment Action Group
Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
[Archived Article]
To read PDF, click here.
From U.S. Food and Drug Administration
Mycobacterium tuberculosis Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here.
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors (January 20, 2004)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
Surgeon General: Treatment in Prison Can Prevent Disease Outside (January 13, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Tuberculosis Treatment Evolves (October 2003)
[Archived Article]
New guidelines reflect subtle but important shifts in strategy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Avoid Rifampin/Pyrazinamide Treatment in TB Patients, CDC Says (August 8, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment of Tuberculosis (June 20, 2003)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Technology Transfer Will Allow Countries to Produce Own TB Drugs (June 5, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment of HIV-Related Tuberculosis (May 2003)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite Knowledge Base Chapter
Scale Up the Global Fight Against Tuberculosis (March 28, 2003)
[Archived Article]
Excerpts from an op-ed column by Gro Harlem Brundtland, director-general of the World Health Organization, and James D. Wolfensohn, president of the World Bank.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Directly Observed Treatment Short Course for TB: A Treatment to Match a Killer Infection (March 27, 2003)
[Archived Article]
Excerpts from an editorial in the Akron Beacon Journal.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Controlling Tuberculosis in India (November 25, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment of Tuberculosis (PDF) (October 2002)
[Archived Article]
Revised guidelines from the American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society of America.
New Drugs Sought for Top Killer of Young Women Worldwide (July 31, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
African Treatment Programs Often Overestimate Tuberculosis Drug Doses (May 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Notice to Readers: Acquired Rifamycin Resistance in Persons With Advanced HIV Disease Being Treated for Active Tuberculosis With Intermittent Rifamycin-Based Regimens (March 15, 2002)
[Archived Article]
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Tuberculosis: Guidelines Changed for Latent TB Treatment (September 21, 2001)
[Archived Article]
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News
The Georgia TB Reference Guide (PDF) (September 2001)
[Archived Article]
From Atlanta Tuberculosis Prevention Coalition
Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations -- United States, 2001 (PDF) (August 31, 2001)
[Archived Article]
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Severe Liver Damage With TB Drugs (May 29, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
An Inexpensive Antibiotic Proves Effective in Reducing Death Among People With HIV and TB in Africa (May 1999)
[Archived Article]
From U.S. Centers for Disease Control and Prevention
A New Treatment for TB (June 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
New Two-Month TB Prophylaxis Regimen Is as Effective as Yearlong Therapy (April 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
A Short Two-Drug Regimen Prevents Active TB (April 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Guidelines for the Administration of Protease Inhibitors and Rifampin in HIV-Positive Patients With Tuberculosis (October 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
TB or Not TB: Do You Have Tuberculosis? (October 1997)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
The Challenge of Multidrug-Resistant Tuberculosis (October 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
Tuberculosis Therapy and the New Protease Inhibitors (November 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
A History of TB Treatment (July 23, 1996)
[Archived Article]
From New Jersey Medical School
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children (January 1, 1994)
[Archived Article]
In American Journal of Respiratory and Critical Care Medicine, from American Lung Association